In vitro activity of caspofungin and voriconazole against uncommon Candida spp.

International Journal of Antimicrobial Agents

Volumn 33, Issue 6, 2009, Pages 595-596

  Enache Angoulvant, Adela ^a   Girard, Aurélie ^a   Poirot, Jean Louis ^a   Hennequin, Christophe ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

Candida; Caspofungin; In vitro activity; Presumptive therapy; Rare species; Voriconazole

Indexed keywords

AGAR; AMPHOTERICIN B; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; PYRROLE DERIVATIVE; VORICONAZOLE;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; BACTERIUM ISOLATION; BLOOD CULTURE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CLINICAL LABORATORY; DISEASE SEVERITY; DRUG INHIBITION; DRUG SCREENING; EPSILOMETER TEST; FECES; HUMAN; IMMUNOCOMPROMISED PATIENT; IN VITRO STUDY; INCUBATION TIME; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SKIN; SPECIES IDENTIFICATION; URINE; VAGINA;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; ECHINOCANDINS; HUMANS; MICROBIAL SENSITIVITY TESTS; PYRIMIDINES; TRIAZOLES;

EID: 64649084948     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.12.002     Document Type: Letter

References (6)

1. Borg-von Zepelin M., Kunz L., Rüchel R., Reichard U., Weig M., and Gross U. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005. J Antimicrob Chemother 60 (2007) 424-428
2. Maxwell M.J., Messer S.A., Hollis R.J., Boyken L., Tendolkar S., Diekema D.J., et al. Evaluation of Etest method for determining fluconazole and voriconazole MICs for 279 clinical isolates of Candida species infrequently isolated from blood. J Clin Microbiol 41 (2003) 1087-1090
3. Chryssanthou E., and Cuenca-Estrella M. Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility testing of yeast species. J Clin Microbiol 40 (2002) 3841-3844
4. Serefko A., Los R., Biernasiuk A., and Malm A. Comparison of microdilution method and E-test procedure in susceptibility testing of caspofungin against Candida non-albicans species. N Microbiol 31 (2008) 257-262
5. Kauffman C.A. Clinical efficacy of new antifungal agents. Curr Opin Microbiol 9 (2006) 483-488
6. Pfaller M.A., Diekema D.J., Ostrosky-Zeichner L., Rex J.H., Alexander B.D., Andes D., et al. Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints. J Clin Microbiol 46 (2008) 2620-2629